Gilead said it plans to produce more than 2 million treatment courses of the drug by the end of the year and anticipates being able to make “several million more” in 2021.
in Business
Gilead said it plans to produce more than 2 million treatment courses of the drug by the end of the year and anticipates being able to make “several million more” in 2021.

